Gili Regev-Yochay

SARS-CoV-2 Omicron XBB.1 variant outbreak in a defined cohort: an epidemiological investigation incorporating longitudinal assessment of humoral response.

Margalit I, Weiss-Ottolenghi Y, Panet E, Indenbaum V, Zuckerman NS, Joseph G, Peretz Y, Barda N, Lustig Y, Regev-Yochay G.

Int J Infect Dis. 2024 Nov. 148:107240. PMID: 39270926

Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers.

Canetti M, Barda N, Lustig Y, Weiss-Ottolenghi Y, Indenbaum V, Peretz Y, Zuckerman N, Asraf K, Amit S, Kreiss Y, Regev-Yochay G.

Vaccine. 2024 Sep 09. 42(26):126308. PMID: 39255646

Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines.

Lustig Y, Barda N, Weiss-Ottolenghi Y, Indenbaum V, Margalit I, Asraf K, Doolman R, Chalkias S, Das R, Elfatarany G, Harats D, Kreiss Y, Regev-Yochay G.

Vaccine. 2024 Sep 17. 42(22):126010. PMID: 38806352

SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.

Lustig Y, Canetti M, Indenbaum V, Peretz Y, Weiss-Ottolenghi Y, Margalit I, Asraf K, Levin T, Zuckerman N, Tomer E, Mandelboim M, Doolman R, Barda N, Regev-Yochay G.

Emerg Infect Dis. 2024 May. 30(5):1050-1052. PMID: 38666742

Obstetric and Early Neonatal Outcomes Following Second and Third COVID-19 Vaccination in Pregnancy.

Peretz-Machluf R, Gilboa M, Bookstein-Peretz S, Segal O, Regev N, Meyer R, Regev-Yochay G, Yinon Y, Toussia-Cohen S.

Isr Med Assoc J. 2024 Jan. 26(1):12-17. PMID: 38420636

Sink-traps are a major source for carbapenemase-producing Enterobacteriaceae transmission.

Regev-Yochay G, Margalit I, Smollan G, Rapaport R, Tal I, Hanage WP, Pinas Zade N, Jaber H, Taylor BP, Che Y, Rahav G, Zimlichman E, Keller N.

Infect Control Hosp Epidemiol. 2024 Mar. 45(3):284-291. PMID: 38149351

Corrigendum to "Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" [Clin Microbiol Infect] 29 (7) (2023) 918-923.

Barda N, Lustig Y, Indenbaum V, Zibly D, Joseph G, Asraf K, Weiss-Ottolenghi Y, Amit S, Kliker L, Abu-Kadar B, Ben-Ami E, Canetti M, Koren R, Katz-Likvornik S, Halpern O, Mendelson E, Doolman R, Harats D, Kreiss Y, Mandelboim M, Regev-Yochay G.

Clin Microbiol Infect. 2024 Mar. 30(3):409-413. PMID: 38128780

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter Season.

Moss S, Jurkowicz M, Nemet I, Atari N, Kliker L, Abd-Elkader B, Gonen T, Martin ET, Lustig Y, Regev-Yochay G, Mandelboim M.

Vaccines (Basel). 2023 Oct 22. 11(10). PMID: 37897026

Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review.

Gilboa M, Baharav N, Melzer E, Regev-Yochay G, Yahav D.

Infect Dis Ther. 2023 Sep. 12(9):2223-2240. PMID: 37704801

Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines.

Gonen T, Barda N, Asraf K, Joseph G, Weiss-Ottolenghi Y, Doolman R, Kreiss Y, Lustig Y, Regev-Yochay G.

JAMA Netw Open. 2023 09 05. 6(9):e2332813. PMID: 37682571